WFDSJ(SH:601010)2023-10-30 16:00Financial Performance - The company's operating revenue for Q3 2023 was ¥461,805,491.75, a decrease of 20.49% compared to the same period last year[3] - The net profit attributable to shareholders for Q3 2023 was ¥2,198,668.55, down 87.81% year-on-year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was ¥938,187.49, a decline of 95.20% compared to the previous year[3] - The basic earnings per share for Q3 2023 was ¥0.0012, representing an 87.88% decrease year-on-year[3] - Total revenue for the first three quarters of 2023 was CNY 1,622,913,097.44, a decrease of 10.8% compared to CNY 1,820,032,938.92 in the same period of 2022[20] - Operating profit for the first three quarters of 2023 was CNY 177,416,413.72, compared to a loss of CNY 193,893,539.25 in the same period of 2022[20] - Net profit for the first three quarters of 2023 was CNY 120,445,383.90, a significant recovery from a loss of CNY 188,589,646.13 in 2022[20] - The net profit for Q3 2023 was ¥120,445,383.90, a significant recovery from a net loss of ¥215,126,290.61 in the same period last year[21] - The net profit attributable to shareholders of the parent company was ¥124,449,562.87, compared to a loss of ¥210,060,759.00 in Q3 2022[21] - The basic and diluted earnings per share for Q3 2023 were both ¥0.07, recovering from a loss of ¥0.12 per share in Q3 2022[21] Assets and Liabilities - The total assets at the end of the reporting period were ¥6,694,989,746.33, an increase of 0.71% from the end of the previous year[4] - Total assets as of September 30, 2023, were CNY 6,694,989,746.33, a slight increase from CNY 6,647,621,420.66 at the end of 2022[16] - Total liabilities decreased to CNY 2,288,399,112.06 from CNY 2,298,475,804.35 at the end of 2022[17] - The company’s total equity increased to CNY 4,406,590,634.27 as of September 30, 2023, compared to CNY 4,349,145,616.31 at the end of 2022[17] Cash Flow - The net cash flow from operating activities for the year-to-date was ¥488,709,030.38, an increase of 29.91%[3] - Cash flow from operating activities for the first three quarters of 2023 was ¥488,709,030.38, an increase from ¥376,180,552.18 in the same period last year[23] - The company reported a total cash outflow from operating activities of ¥1,632,688,611.87, compared to ¥2,298,219,758.02 in the previous year[23] - The total cash and cash equivalents at the end of Q3 2023 amounted to ¥1,154,181,474.93, up from ¥829,947,456.23 at the end of Q3 2022[24] - Cash and cash equivalents increased to CNY 1,171,546,723.52 as of September 30, 2023, up 61.7% from CNY 725,477,591.73 at the end of 2022[15] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 90,955[9] - Jiangsu Wenfeng Group Co., Ltd. held 27.53% of the shares, with 334,901,683 shares pledged[9] - Jiangsu Wanfeng Group Co., Ltd. holds 508,724,567 shares, accounting for 27.53% of the total share capital[11] - The company has conducted a repurchase of 39,303,800 shares, representing 2.13% of the total share capital, with an average repurchase price of RMB 2.54 per share[12] - As of September 30, 2023, Jiangsu Wanfeng Group has pledged 334,901,683 shares, which is 65.83% of its holdings and 18.12% of the total share capital[11] - The company’s stockholder Zheng Suzhen has 275,000,000 shares, which are currently frozen[11] - The company has a total of 36,000,000 shares involved in a repurchase agreement, accounting for 1.95% of the total share capital[11] Corporate Actions - The company reported an investment income of RMB 24.03 million from the sale of a 30.4348% stake in Nantong Hualikang Medical Technology Co., Ltd.[12] - The company completed the share repurchase using a total amount of RMB 99,966,707.93, excluding transaction fees[12] - The company’s board of directors and supervisory board were re-elected, with new appointments including Wang Yao as chairman and He Lanhong as general manager[12] - The company’s repurchase plan was approved on April 27, 2023, to support employee stock ownership plans[12] - The company received a cash supplement of RMB 50 million from its controlling shareholder for losses incurred from a private equity fund investment[12] Investment Income - The company reported a significant increase in investment income of CNY 31,608,644.33 for the first three quarters of 2023, compared to a loss of CNY 70,579,401.44 in the same period of 2022[20]